TAAR1 and myeloid sarcoma: Notably, a recent report highlighted the expression of TAAR1 in macrophages/microglia bordering multiple sclerosis (MS) lesions [32], supporting TAAR1 as a novel pharmacological target in cells directly implicated in neuroinflammation.